(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 7.76% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.92%.
Mckesson's revenue in 2026 is $403,430,000,000.On average, 20 Wall Street analysts forecast MCK's revenue for 2027 to be $52,409,447,052,204, with the lowest MCK revenue forecast at $49,998,514,401,297, and the highest MCK revenue forecast at $55,445,921,584,515. On average, 19 Wall Street analysts forecast MCK's revenue for 2028 to be $56,341,081,152,312, with the lowest MCK revenue forecast at $52,532,776,408,530, and the highest MCK revenue forecast at $60,151,309,160,910.
In 2029, MCK is forecast to generate $60,803,536,341,636 in revenue, with the lowest revenue forecast at $55,236,766,535,775 and the highest revenue forecast at $67,158,964,926,108.